Can Prostate Cancer Spread to the Bones?

Prostate cancer spreads to bone more often than to any other site, making it the most common location for metastasis in this disease. It typically affects the spine, pelvis, ribs and femur. Unusually for a cancer that spreads to bone, prostate cancer metastases tend to build bone rather than destroy it, a distinguishing pattern from most other cancers. Bone pain is the most common symptom, and detection relies primarily on bone scan.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Bone is where prostate cancer goes when it spreads, more than the lungs or liver. The spine and pelvis are particularly common sites, and patients often present with persistent back or hip pain that doesn’t settle. What’s interesting biologically is that these deposits tend to form new bone rather than eat away at it, which is the opposite pattern seen in most cancers. That distinction actually shapes how we monitor and treat it.”

Understanding this pattern of spread clarifies why bone monitoring matters so much in this disease.

• Bone marrow environment : Prostate cancer cells appear to have a particular affinity for the bone marrow environment, which favours their growth once they arrive there.
• Axial skeleton preference : The spine, pelvis, ribs and femur are affected far more often than the arms or skull, reflecting where these deposits typically settle.
• Osteoblastic pattern : Unlike most cancers, which erode bone, prostate cancer metastases usually stimulate new bone formation, a distinctive radiological appearance.
• A common, not rare, event : Bone involvement is a frequent feature of advanced prostate cancer, which is why monitoring for it is routine in advanced disease.

Recognising this pattern is central to comprehensive prostate cancer treatment, where bone health monitoring runs alongside cancer control.

Once spread to bone is suspected, a defined pathway of detection and treatment follows.

• Bone scan : This remains the standard first line imaging test for detecting bone metastasis, showing areas of increased bone activity.
• PSMA-PET : Increasingly used for greater sensitivity, this scan can detect bone involvement that a standard bone scan may miss, particularly early disease.
• Bone targeted therapy : Bisphosphonates or denosumab strengthen bone and reduce the risk of fracture and other skeletal complications alongside cancer treatment.
• Radiation for symptomatic sites : Painful individual bone lesions often respond well to targeted radiation, providing meaningful relief.

Understanding how this disease is tracked builds directly on the broader picture in our guide to prostate cancer detection, where early diagnosis reduces the chance of reaching this stage undetected.

Dr. Sandeep Nayak is a surgical oncologist with 24 years of experience and a fellowship in laparoscopic and robotic onco-surgery. His approach to prostate cancer includes appropriate imaging to detect bone involvement early, and coordinating bone targeted therapy alongside systemic treatment when metastasis is confirmed. This means treating bone health as part of the overall cancer management plan, not a separate consideration.

Recognising bone as prostate cancer’s preferred site of spread shapes how the disease is monitored from diagnosis onward. Persistent bone pain in a man with prostate cancer deserves prompt evaluation, since early detection of metastasis allows bone protective treatment to begin before complications such as fracture occur. Managing bone health alongside the cancer itself is what gives patients the best functional outcome through advanced disease.

References

1. Bone metastasis biology in prostate cancer – National Library of Medicine
2. PSMA-PET detection of bone metastasis in prostate cancer – National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.